Mitsutoshi Nakada Selected Research

2-fluorohexadecanoic acid

1/2020

Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsutoshi Nakada Research Topics

Disease

71	Neoplasms (Cancer) 08/2022 - 01/2003
52	Glioma (Gliomas) 04/2022 - 01/2003
45	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2003
9	Brain Neoplasms (Brain Tumor) 01/2020 - 11/2005
8	Aneurysm (Aneurysms) 01/2021 - 01/2004
7	Hydrocephalus (Hydrocephaly) 01/2022 - 05/2010
6	Neoplasm Metastasis (Metastasis) 06/2019 - 01/2003
5	Astrocytoma (Pilocytic Astrocytoma) 09/2012 - 10/2005
4	Inflammation (Inflammations) 01/2022 - 12/2009
4	Germinoma 01/2021 - 08/2015
4	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 01/2004
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 08/2015
4	Ependymoma 01/2021 - 01/2018
4	Hemorrhage 01/2020 - 11/2016
3	Lymphoma (Lymphomas) 06/2022 - 07/2015
3	Cysts 01/2019 - 02/2017
3	Intellectual Disability (Idiocy) 06/2018 - 10/2016
3	Meningioma (Meningiomas) 07/2016 - 02/2009
3	Medulloblastoma 01/2016 - 08/2009
2	Disease Progression 12/2021 - 06/2021
2	Pituitary Neoplasms (Pituitary Adenoma) 10/2021 - 04/2016
2	Pathologic Constriction (Stenosis) 01/2021 - 10/2018
2	Brain Ischemia (Cerebral Ischemia) 05/2020 - 01/2018
2	Meningeal Carcinomatosis 01/2020 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
2	Headache (Headaches) 01/2019 - 03/2017
2	Necrosis 06/2018 - 01/2018
2	Thalassemia 06/2018 - 10/2016
2	Adenocarcinoma of Lung 12/2017 - 03/2015
2	False Aneurysm (Pseudoaneurysm) 11/2016 - 05/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016 - 01/2013
2	Lung Neoplasms (Lung Cancer) 01/2016 - 03/2015

Drug/Important Bio-Agent (IBA)

13	Messenger RNA (mRNA)IBA 01/2021 - 05/2003
11	Temozolomide (Temodar)FDA LinkGeneric 12/2021 - 04/2007
10	Pharmaceutical PreparationsIBA 08/2022 - 02/2011
10	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2004
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2003
9	Biological ProductsIBA 10/2019 - 01/2003
8	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 05/2003
8	Glycogen Synthase KinasesIBA 01/2020 - 02/2009
7	Phosphotransferases (Kinase)IBA 01/2021 - 11/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2007
5	MethyltransferasesIBA 01/2020 - 11/2010
5	LigandsIBA 01/2019 - 09/2006
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 07/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 05/2010
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020 - 05/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2013
4	AcidsIBA 03/2019 - 05/2010
4	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2003
4	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2016 - 12/2009
3	Transcription Factors (Transcription Factor)IBA 04/2022 - 02/2011
3	AntibodiesIBA 11/2021 - 02/2009
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2018
3	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 12/2019
3	Therapeutic UsesIBA 01/2020 - 02/2009
3	Erythropoietin FDA Link 01/2020 - 01/2013
3	osimertinibIBA 01/2020 - 01/2016
3	Glycogen Synthase (Synthase I)IBA 10/2016 - 10/2013
3	EphrinsIBA 12/2013 - 09/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2011 - 12/2009
2	NivolumabIBA 12/2021 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 04/2007
2	Glial Fibrillary Acidic ProteinIBA 10/2020 - 02/2011
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 10/2020 - 12/2008
2	Receptor for Advanced Glycation End ProductsIBA 05/2020 - 11/2019
2	Proteoglycans (Proteoglycan)IBA 05/2020 - 09/2005
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 01/2013
2	alectinibIBA 01/2020 - 03/2015
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 07/2014
2	O-(6)-methylguanineIBA 01/2020 - 10/2013
2	Discoidin Domain Receptor 1IBA 01/2020 - 01/2013
2	Ephrin-B2 (Ephrin B2)IBA 01/2019 - 03/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2018 - 11/2004
2	isocitric acid (isocitrate)IBA 06/2018 - 10/2014
2	ProlactinIBA 02/2018 - 04/2016
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2018 - 07/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 10/2009
2	CrizotinibIBA 12/2017 - 03/2015
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 08/2016 - 01/2016
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2016 - 02/2009
2	GadoliniumIBA 07/2016 - 05/2012
2	NF-kappa B (NF-kB)IBA 01/2016 - 10/2006
2	Glutamic Acid (Glutamate)FDA Link 07/2015 - 07/2014
2	MRK 003IBA 01/2015 - 02/2013
2	N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA 10/2013 - 02/2009
2	Alkylating AgentsIBA 01/2012 - 02/2011
2	Cyclin-Dependent Kinase Inhibitor p16IBA 02/2011 - 10/2009

Therapy/Procedure

32	Therapeutics 08/2022 - 04/2007
10	Drug Therapy (Chemotherapy) 04/2022 - 04/2007
9	Radiotherapy 04/2022 - 11/2010
9	Craniotomy 04/2022 - 12/2009
5	Lasers (Laser) 03/2010 - 05/2004
3	Ventriculostomy 02/2021 - 07/2016
3	Stents 01/2021 - 11/2016
2	Ventriculoperitoneal Shunt 01/2022 - 08/2016
2	Chemoradiotherapy 06/2019 - 07/2013
2	Decompression 01/2019 - 01/2018
2	Operative Surgical Procedures 01/2018 - 01/2015
2	Surgical Instruments (Clip) 09/2017 - 01/2004